Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL20162135

CC(=O)N1CCc2cc(C(=O)Nc3cn(Cc4cccc(C(F)(F)F)c4)cn3)ccc2C1.O=C(O)C(F)(F)F

nearest known ligand 0.48

Full drug profile on Sugi Atlas →

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
KDM4C Q9H3R0 1/20 0.46
TAS2R8 Q9NYW2 1/20 0.44
ABCB1 P08183 1/20 0.43
KCNK3 O14649 1/20 0.42
TP53 P04637 1/20 0.41
KCNH2 Q12809 1/20 0.41
NTRK1 P04629 2/20 0.40
DDR1 Q08345 1/20 0.40
NTRK3 Q16288 1/20 0.40
NTRK2 Q16620 1/20 0.40
DDR2 Q16832 1/20 0.40
RORC P51449 1/20 0.40
PTGER4 P35408 2/20 0.40
NAMPT P43490 2/20 0.40
PTGER2 P43116 1/20 0.40
P2RY14 Q15391 1/20 0.40
FAAH O00519 1/20 0.39
CYP3A4 P08684 1/20 0.38
CYP2C9 P11712 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20367488 0.97 KDM4C (0.47) KDM4CTAS2R8ABCB1KCNK3TP53
SCHEMBL20162109 0.88 TAS2R8 (0.49) KDM4CTAS2R8ABCB1KCNH2NTRK1
SCHEMBL20367121 0.87 ABCB1 (0.44) KDM4CTAS2R8ABCB1NAMPT
SCHEMBL20364403 0.85 TAS2R8 (0.53) TAS2R8RORC
SCHEMBL20367330 0.84 ABCB1 (0.44) KDM4CTAS2R8ABCB1NTRK1DDR1
SCHEMBL20367429 0.82 KDM4C (0.44) KDM4CTAS2R8ABCB1KCNH2NAMPT
SCHEMBL20162181 0.81 KDM4C (0.47) KDM4CTAS2R8ABCB1KCNH2NAMPT
SCHEMBL20367354 0.81 TAS2R8 (0.47) KDM4CTAS2R8KCNH2PTGER4P2RY14
SCHEMBL20162177 0.81 KDM4C (0.46) KDM4CTAS2R8KCNH2P2RY14CYP3A4
SCHEMBL20162137 0.81 KDM4C (0.42) KDM4CTAS2R8ABCB1KCNH2PTGER4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10294237-B2 Bicyclic heterocyclic amide derivative SUMITOMO DAINIPPON PHARMA CO., LTD. (JP) 2019-05-21 US disclosed
US-20180194773-A1 BICYCLIC HETEROCYCLIC AMIDE DERIVATIVE SUMITOMO DAINIPPON PHARMA CO., LTD. (JP) 2018-07-12 US disclosed
EP-3323809-A1 BICYCLIC HETEROCYCLIC AMIDE DERIVATIVE Sumitomo Dainippon Pharma Co., Ltd. (JP) 2018-05-23 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10294237-B2 Bicyclic heterocyclic amide derivative NR0B1, NR2E1, NR0B2 KDM4C 1041/4885TAS2R8 2479/4885ABCB1 1642/4885
US-20180194773-A1 BICYCLIC HETEROCYCLIC AMIDE DERIVATIVE NR0B1, NR2E1, NR0B2 KDM4C 1041/4885TAS2R8 2479/4885ABCB1 1642/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.